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Background: Cardiac Amyloidosis (CA) is uncommon but has high morbidity and mortality. Biopsy remains the cornerstone of management. CMR is 
important in diagnosing CA but its ability to distinguish between CA subtypes has not been studied.
Methods: Patients diagnosed with amyloidosis from 1/2005 to present were selected from a hospital database. After cross-referencing with the 
CMR database, 65 patients had confirmed CA. Charts were reviewed for demographic, biopsy and vital status.
results: Of the 65 patients with abnormal CMR and suspected CA, 33 had biopsy proven AL amyloid (lambda 22; kappa 11; 2 unknown), 16 had 
TTR amyloid (Val122lle, 6; wild type 7; unknown 2; thr60ala 1), 1 Finnish type, 1 AA amyloid, 2 unknown; 44 men, 21 women; 49 White, 15 African-
American, 1 of unknown race. Raw CMR images were reviewed and analyzed – 16 patients had both pre- and post-contrast T1 maps and pre-
contrast T2 maps available, 3 had pre-contrast T1 and T2, 4 pre- and post-contrast T1, and 11 pre-contrast T2. Analysis revealed that TTR patients 
had significantly higher myocardial ECV (Table 1). An ROC curve model discriminated the two CA subtypes with an AUC of 0.864 +/-0.087 using 48% 
as the optimal ECV cut point.
Table 1.
AL TTR P
ECV 40.1±1.2 58.0±1.1 <0.05
T1Blood pre 1508±228 1559±149 0.97
T1blood post 326±82 286±82 0.27
T1myo pre 1000±151 1078±65 0.13
T1myopost 387±93 286±83 0.04
T2Blood 230±64 239±67 0.86
T2Myo 62±7 61±10 0.39
Hematocrit 0.36 +/- 0.06 0.36 +/- 0.06 0.72
conclusion: Patients with TTR CA have significantly higher ECV than patients with AL CA. This phenomenon may result from the indolent course 
of TTR CA, leading to delayed clinical presentation and greater cardiac involvement at the time of CMR study. These important findings need 
confirmation in a prospective study.
